Sustained release hormonal preparations. 9. Plasma levels and accumulation into various tissues of 6-methyl-17 alpha-acetoxy-4,6-pregnadiene-3,20-dione after oral administration or absorption from polydimethylsiloxane implants.
D000042:Absorption; D000284:Administration, Oral; D000311:Adrenal Glands / Q000032:analysis; D000818:Animals; D002247:Carbon Isotopes; D005243:Feces / Q000032:analysis; D005260:Female; D007668:Kidney / Q000032:analysis; D008099:Liver / Q000032:analysis; D008297:Male; D008535:Megestrol / Q000008:administration & dosage / Q000097:blood / Q000378:metabolism / Q000652:urine; D011278:Pregnanes / Q000378:metabolism*; D011372:Progestins / Q000378:metabolism*; D011865:Radioisotope Dilution Technique; D051381:Rats; D012828:Silicones; D013997:Time Factors; D014316:Tritium
D002247:Carbon Isotopes; D011278:Pregnanes; D011372:Progestins; D012828:Silicones; D014316:Tritium; D008535:Megestrol